WITHDRAWN Estimating trends in simultaneous administration of HPV vaccine with other recommended vaccines

Pingali Cassandra Co-Author
CDC
 
Laurie Elam-Evans Co-Author
CDC
 
David Yankey Co-Author
CDC
 
Madeleine Valier Co-Author
CDC
 
James Singleton Co-Author
CDC
 
Michael Chen First Author
CDC
 
Sunday, Aug 3: 2:20 PM - 2:35 PM
1214 
Contributed Papers 
Music City Center 
There is an interest in investigating the simultaneous administration of the HPV vaccine with other vaccines recommended for adolescents. This study investigates the trend in the prevalence of simultaneous administration of the HPV, Tdap (tetanus, diphtheria, and acellular pertussis) and MenACWY (quadrivalent meningococcal conjugate vaccine) vaccines in a single visit using data from the National Immunization Survey-Teen (2015-2023). Weighted regression models were used to estimate the trend. The findings reveal a significant increase in prevalence of simultaneous administration of the HPV, Tdap and MenACWY vaccines, from 22.6% (2015) to 45.8% (2023), with a linear regression slope of 3.1 (95% CI: 2.9-3.3). The trends were similar for both males and females, with slopes of 3.4 (95% CI: 3.2-3.7) and 2.8 (95% CI: 2.4-3.1), respectively. Further analyses will explore trends in prevalence of simultaneous administration by race and ethnicity and adjusted for metropolitan statistical area (MSA). In summary, we observed an increasing trend of about 3 percentage points per year in the prevalence of simultaneous administration of the HPV, Tdap, and MenACWY vaccines in a single visit.

Keywords

National Immunization Survey

HPV vaccination

trends

adjusted prevalence

simultaneous administration 

Main Sponsor

Government Statistics Section